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Novel 3D Liquid Cell Culture 
Method for Anchorage-
independent Cell Growth, Cell 
Imaging and Automated Drug 
Screening
Natsuki Abe-Fukasawa1, Keiichiro Otsuka1, Ayako Aihara1, Nobue Itasaki2 & Taito Nishino1
Cells grown in three-dimensional (3D) cultures are more likely to have native cell-cell and cell-matrix 
interactions than in 2D cultures that impose mechanical constraints to cells. However, most 3D cultures 
utilise gel matrix which, while serving as a scaffold, limits application due to its solid and opaque nature 
and inconsistency in cell exposure to exogenous signals. In 3D culture without gel matrix, cells tend to 
adhere to each other and form clumps with necrotic zone at the centre, making them unsuitable for 
analyses. Here we report that addition of low-molecular-weight agar named LA717 to culture media 
allows cells to grow as dispersed clonal spheroids in 3D. LA717 maintains cells dispersed and settled 
to the bottom of the medium while keeping the medium clear with little additional viscosity, making 
it suitable for microscopic observation. Importantly, cancer spheroids formed in LA717-containing 
medium show higher sensitivity to anti-cancer drugs such as Trametinib and MK-2206 that are not as 
effective in 2D. Because of the small and consistent size of spheroids, cell viability and drug toxicity are 
readily detectable in automated imaging analysis. These results demonstrate that LA717 offers a novel 
3D culture system with great in vivo reflection and practicality.
Cells in the physiological microenvironment undergo complex cell-cell and cell- extracellular matrix (ECM) 
interactions as well as being exposed to extracellular signals, all of which are the basis of multicellular organisms. 
Nonetheless, most cell-based in vitro studies conventionally employ two-dimensional (2D) monolayer cell culture 
which does not fully reflect cyto-architecture, cell interaction and response to exogenous stimuli. For example, 
large scale drug-screening often employs 2D cultures for practicality, but this may mask active compounds or 
select false-positives that turn out to be ineffective in in vivo studies1,2. As such, in vitro cell culture methods with 
high reliability to predict in vivo activities are desirable for the successful drug screening as well as for other cell 
studies.
Current 3D culture methods involve either the use of scaffolds such as gel matrix and micro-carriers, or liquid 
cultures on low-attachment plates, in hanging drops or in rotation3,4. While they have many advantages compared 
to 2D cultures, they also have practical challenges. For example, commercial gel matrices derived from basal lamina 
of osteosarcoma (e.g. Matrigel®) serve as a scaffold and maintain epithelial features very well; however, application 
of drugs is often hindered by the semi-solid matrix, making it unsuitable for high throughput screening (HTS). The 
temperature-dependent solidification and high opacity are also disadvantageous for automated liquid handling and 
imaging3–6. Liquid culture without gel matrix on low-attachment plates, on the other hand, can be handled as a clear 
liquid thus offering practicality. However, cell aggregates (spheres or spheroids) generated in the medium often 
form large clumps of >500 μm diameter due to cell adhesion, which causes a slow cell proliferation rate and poor 
diffusion of nutrients. Such generated large-sized spheroids may lead to pseudo-resistance to anti-cancer drugs5. 
Hanging drop method generates a uniform size of spheroid but requires considerable effort and special apparatus4,6. 
Microfluidic technologies provide a variety of practical platforms for 3D cell cultures and cell-based assays. However, 
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these technologies remain relatively expensive owing to the microfabricated instruments required and the complex-
ity of the process7,8. Furthermore, current cell-based HTS employs automated imaging system which allows analysis 
of cells with simultaneous data collection on several parameters, so-called high content imaging analysis (HCA) 
or high content screening (HCS) technology9–11. Several studies have examined implementation of 3D cultures in 
HCA/HCS using Matrigel, methyl cellulose or special micro-patterned plates to form spheroids12–16. However, a 
more practical and efficient method is desired to perform HCA/HCS in 3D cultures17.
In this study, we explored a novel 3D cell culture method by screening natural polysaccharides that would 
promote uniform suspension of cells on low-attachment culture plates while maintaining the practicality for 
liquid handling. We have identified low molecular weight agar (LA) polymers as suitable additives for the 3D 
cell culture platform and named it LA717. By lowering the molecular weight of agar polymers, it has become 
possible to increase the solubility of agar to the medium. We found that LA717 holds cells in the medium, keeping 
movement at a minimum and thus maintaining the even distribution of cells. Moreover, such well-distributed 
cells rarely make new contacts to others, hence, individual spheroids are largely maintained as clones. Although, 
cell adhesions following cell division or natural contacts are not affected by LA717. Lastly, we demonstrate that 
spheroids formed in the LA717-containing medium effectively reveal the action of anti-cancer drugs and are thus 
suitable to HCS, offering a novel 3D cell culture system which elicits more efficient and practical HCS systems.
Results
Selection and characterization of low molecular weight agar LA717 for 3D cultures. 
Polysaccharides are carbohydrates consisting of sugar molecules bound as polymers. The examples include agar, 
agarose and methyl cellulose, that have been used traditionally for biological studies such as colony-forming 
assays. We examined eight polysaccharides at different concentrations on lung cancer cells A549 for effective cell 
dispersion and uniform spheroid formation on low-attachment plates (Supplementary Table S1). With regards to 
agar18–20, which is a mix of agarose and agaropectin, we tested two types, one with a low average molecular weight 
(43,000)21,22 and a standard (290,000) one. Agar with standard molecular weight and other polysaccharides 
formed variable sizes of aggregates at certain concentrations in the medium due to the low solubility to DMEM 
(Supplement Table S1). Even when high solubility was achieved with some polysaccharides, many of them did 
not cause cell dispersion (Supplement Table S1). In some conditions, cells were successfully dispersed in the pol-
ysaccharides, however, cells were suspended in the medium without falling to the bottom of the plate. This is not 
a problem as a 3D culture, however, it is not ideal for imaging analyses and was hence eliminated (Supplementary 
Table S1). We found low molecular weight agar to be the most satisfactory polysaccharide for the above purpose 
at a concentration of 0.03% (w/v) and named it LA717.
We further investigated how cells are populated in the culture with LA717. As shown in Fig. 1a,b, addition of 
LA717 to the culture medium successfully dispersed A549 cells and formed uniform spheroids, whereas without 
LA717 cells formed large clumps that accumulated at the edge of the wells. In addition, it was noted in time-lapse 
analyses that cells in LA717-containing medium largely stay at the same position during the culture. This is in 
contrast to the culture without LA717 where the cells move due to the convection of the medium, that causes cell 
assembly, cell adhesion and formation of clumps (Supplementary Video. S1). The average diameter of A549 sphe-
roids in LA717-containing medium after a 7-day culture was 63 μm, with the mode at 50 μm (Fig. 1c). Scanning 
electron microscope (SEM) analysis showed a mix of rugged and flat surfaces both covered with microvilli 
(Supplementary Fig. S1). In agreement with the static culture condition, we confirmed clonal growth in almost 
all of the spheroids in LA717-containing medium when co-culturing two populations of HEK-293 cells, labelled 
or not-labelled with a fluorescent marker (Supplementary Fig. S2). These results demonstrate that LA717 causes 
uniform dispersion of cells and suppresses the medium convection while keeping the medium as liquid, resulting 
in individual cells forming clonal spheroids. Large-sized spheroids were prevented because of LA717 inhibiting 
the fusion of spheroids.
Next, we characterised the viscosity, osmotic pressure, absorbance at 450 nm and pH of LA717-containing 
DMEM by comparing them to those of DMEM controls (with or without water, a vehicle control) and DMEM 
with 0.4% agarose or 0.03% methyl cellulose as an example of highly viscous medium. The differences in the 
viscosity between DMEM with and without LA717 were, although statistically significant, not noticeable in the 
practical handling, as both were able to be handled as a liquid. By comparison, the viscosity of DMEM with aga-
rose was far greater at 0.4%, the concentration employed for soft agar colony formation assays23 (Supplementary 
Table S2). Furthermore, addition of 0.03% methyl cellulose to the medium resulted in a larger increase in viscosity 
than 0.03% LA717. However, uniform cell dispersion was not induced (Supplementary Tables S1,S2). The data 
suggest that a slight increase of viscosity by LA717 is unlikely attributed to the cell-dispersing effect. Osmotic 
pressure was slightly reduced by addition of LA717 or water, likely due to the volume taken by 0.03%. The slight 
change in pH by additional LA717 was considered well within the range of the buffering capacity DMEM nor-
mally has. With regard to the optical transparency, LA717-containing medium showed a similar absorbance to 
that of DMEM. Hence, addition of LA717 does not compromise practicality in cell culture and medium handling 
such as cell seeding, reagent addition, microscopic observation and medium changes.
LA717 improves cell proliferation of cancer cells without serving as scaffold. When anchorage- 
dependent cells are liquid-cultured on low-attachment plates, cell proliferation tends to be compromised due to 
the loss of anchorage and subsequent large aggregate formation. To investigate whether cancer cell dispersion by 
LA717 impacts cell proliferation, we cultured A549 cells in LA717-containing medium on low-attachment plates 
for 7 days and examined cell viability, proliferation and cell death using WST-8, ATP and Trypan blue assays. 
A549 cells grew faster in LA717-containing medium as compared with the absence of LA717, both of which were 
in the anchorage-independent condition (Fig. 2a–c). The positive effect of LA717 on cell proliferation was also 
observed in other cancer cell lines T98G, MNNG/HOS, HepG2, A375, HCT116, MDA-MB-231, A431, MCF-7 
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and SKOV3 (Table 1). By contrast, LA717 had no significant effect on the growth of MIA PaCa-2, HeLa, AGS and 
LNCap cells (Table 1). Among them, MIA PaCa-2 and AGS did not form spheroids and remained as single cells 
in the presence or absence of LA717 (data not shown). These results suggest that spheroid forming ability may be 
one of the factors allowing LA717 to exert its growth-enhancing effect. Other factors that make HeLa and LNCap 
cells refractory to LA717 are yet to be explored. To further confirm anchorage-independent cell proliferation, we 
coated plastic plates with LA717 and examined the effect in 2D monolayer cultures. A549 cells did not adhere 
to the surface of LA717-coated plates, demonstrating that LA717 does not serve as a cell scaffold (Fig. 2d–g). As 
the medium per se does not contain LA717, the cells aggregated and floated as clumps in the medium (Fig. 2e,g). 
Furthermore, addition of LA717 to the culture medium on conventional cell-attachable culture plates allowed 
A549 cells to grow on the plastic surface and didn’t alter the growth rate (Fig. 2h). These results suggest that 
LA717 does not serve as a scaffold and improves cell proliferation likely by inhibiting the formation of large 
aggregates which would cause nutrient deficiency.
LA717 has little effect on gene expression profile in the 3D culture. We next performed DNA 
microarray analyses to evaluate the effect of LA717 on the global transcription. Figure 3a–d shows scatter 
plots on which each dot represents the expression level of individual genes in A549 cells after culturing for 7 
days in four different conditions; 2D culture on cell-attachable plates with or without LA717, and 3D culture 
on low-attachment plates with or without LA717. Comparisons were made in four combinations as shown in 
Fig. 3a–d and the number of genes with two-times greater changes in given comparison were shown in Fig. 3e. 
Consistent with the result of Fig. 2d–g, comparison between 2D cultures with and without LA717 showed little 
difference (3 genes altered by more than twofold among the 39130 genes examined, Fig. 3a,e). Comparisons 
between 2D and 3D detected many gene expressions altered, in both absence and presence of LA717 (436 and 725 
genes out of 39130 genes, respectively) (Fig. 3c–e). In contrast, comparison between the presence and absence 
of LA717 in 3D cultures resulted in 72 out of 39130 genes altered (Fig. 3b,e). This was far lower compared to the 
2D vs 3D differences noted in Fig. 3c–e, thus, the impact LA717 gives on gene expression profile is relatively low.
Supplementary Table S3 shows the twenty most up- or down-regulated protein-coding genes in cells cultured 
in 3D in the presence of LA717 compared to the 2D culture. Of those, changes in the expression of carcinoem-
bryonic antigen-related cell adhesion molecule (CEACAM) 5 and 6 were confirmed using real-time quantitative 
PCR (Fig. 3g,h), along with CEACAM1 as a control (Fig. 3f). CEACAM5 and 6 were up-regulated over time in 
the 3D condition with LA717. In contrast, there was no significant difference in CEACAM1 expression between 
cells cultured in 2D and 3D after 7–10 days, although on day 4 the expression was higher in 3D (Fig. 3f). The data 
Figure 1. Identification of low-molecular weight agar (LA717) as a substrate for 3D cell culture. (a,b) A549 cells 
cultured for 7 days in the wells of low-attachment plates in the medium without (a) or with 0.030% (w/v) LA717 
(b). Scale bar, 500 μm. (c) Size distribution of A549 spheroids formed on low-attachment plates in DMEM 
with 0.030% (w/v) LA717 after a 7-day culture. Shown is the ratio to the total spheroid number. Spheroids were 
defined as cell aggregates that had more than five cell nuclei. Data represent means ± SD for 3 independent 
experiments.
www.nature.com/scientificreports/
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is consistent with the report that regulation of CEACAM1 gene expression was different from that of CEACAM5 
and 6 genes24. Taken together, while 2D versus 3D conditions give a strong impact on gene expression profile, 
additional LA717 has relatively little effect on gene regulation.
Figure 2. LA717 improves the growth of A549 cells in 3D cultures. (a–c) LA717 promotes cell viability. A549 
cells were cultured on low-attachment plates without (white columns) or with (black columns) LA717 and 
analysed with WST-8 (a), ATP (b), and Trypan blue exclusion assays (c). (d–g) LA717 does not function as a 
cell scaffold. A549 cells were grown on cell-attachable plates in the absence or presence of LA717 coating and 
cultured for 1 (d,e) and 2 days (f,g). A549 cells do not adhere to LA717-coated plate and instead form spheroids 
in 3D. The bars represent 200 μm. (h) LA717 has no effect on cell proliferation when cells are grown in 2D on 
attachable plates. A549 cells were grown in 96-well cell-attachable plates for 1 day, after which time the medium 
was replaced with DMEM with LA717 and cultured for up to 5 days. The number of live cells was counted 
using the ATP assay. Y-axis shows Relative Light Unit. In (a), (b), (c) and (h), data represent means ± SD for 3 
independent experiments. Statistical significance was analysed with Tukey’s test.
www.nature.com/scientificreports/
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Anti-cancer drug evaluation in 3D culture with LA717. To assess the benefit of LA717 for drug 
screening, we examined the sensitivity of A549 cells to anti-cancer drugs in the presence or absence of LA717 
on low-attachment plates. We chose the anti-mitotic drug Paclitaxel25 and the MEK1/2 inhibitor Trametinib26 as 
established anti-cancer drugs, and an AKT inhibitor MK-220627 as a candidate anti-cancer drug, for the cytotox-
icity analyses. Figure 4a and Supplementary Table S4 show the sensitivity of A549 cells to Paclitaxel, Trametinib 
and MK-2206 in 2D on cell-attachable plates and in 3D on low-attachment plates in the presence of LA717. As for 
Paclitaxel, the effect of inhibiting cell survival was similar in both 2D and 3D cultures. In contrast, Trametinib and 
MK-2206 were shown to be more effective in 3D than in 2D. In fact, the value of IC50 of MK-2206 on inhibition 
of cell growth was more than 10 times different between 2D and 3D cultures (Table S4). The result demonstrates 
that the effect of both Trametinib and MK-2206 (the drugs proven to be effective in vivo26,27), is masked in the 2D 
assessment, but is clearly manifested in 3D cultures with LA717. The data also suggest that the action of certain 
signal transduction inhibitors can be elucidated at lower concentrations in 3D culture.
We also examined caspase activity on Paclitaxel and MK-2206 to test the specificity of drug action in the 
culture. As expected as an anti-mitogenic inhibitor25, Paclitaxel induced caspase activity in a dose-dependent 
manner in both 2D and 3D with LA717 (Fig. 4b). In contrast, MK-2206, which inhibits cell proliferation inde-
pendent of caspase28,29, did not induce caspase activity in 2D or 3D. The data demonstrates that the 3D culture 
with LA717 faithfully presents the drug function and hence is likely a useful method for evaluating the activity 
of anti-cancer drugs.
Next, we examined the impact of serum on the efficacy of Paclitaxel and MK-2206 using 2D and 3D cul-
tures, as serum-free media are often used to evaluate anti-cancer drugs on cancer stem cells. We employed the 
MCF-7 human breast adenocarcinoma cell line for this experiment because MCF-7 cells exhibit more vigorous 
growth in the absence of serum in the 3D condition than A549 cells (data not shown). Supplementary Figure S3 
and Table S5 show the sensitivity of MCF-7 cells to Paclitaxel and MK-2206 when cultured in 2D or 3D with or 
without LA717. Similarly to what is seen in A549 in Fig. 4a, the cytotoxic effect of MK-2206 on MCF-7 was more 
prominent in 3D than in 2D in the presence of serum, although MCF-7 showed a slightly higher sensitivity to 
MK-2206 in 2D (Fig. S3) compared to A549. The effect of Paclitaxel was similar in both 2D and 3D on MCF-7, as 
was seen on A549 cells. In the serum-free condition, however, the effect of 3D culture with LA717 in exhibiting 
the cytotoxicity of MK-2206 was no longer observed, as both 2D culture and 3D culture with LA717 showed a 
similar efficacy of MK-2206 (Fig. S3). Hence the effect of 3D culture on the toxicity of MK-2206 on MCF-7 is 
serum-dependent.
Next, we compared the effect of MK-2206 between 3D culture with LA717 and conventional soft agar assay 
(Fig. S4). The efficacy of MK-2206 on A549 cell growth in 3D culture with LA717 was similar to that in the 
soft-agar culture. In contrast, 3D cultures without LA717 or 2D cultures showed lower efficacy compared to 
that with LA717. The result indicates that the 3D culture with LA717 is comparable to soft agar cultures with 
the added benefit of practicality in handling and microscopic observation. The lower sensitivity of cells cultured 
under 3D conditions without LA717 might be due to decreased drug permeability of large sized-spheroids.
3D culture with LA717 increases feasibility in high-content analysis/screening system. We 
next investigated whether LA717 is suitable for drug evaluation with automated cell imaging apparatus, that is, 
high-content analysis/screening (HCA/HCS). As shown in Fig. 5a, A549 cells grown in low-attachment 96-well 
plates in the absence of LA717 formed large clumps that tend to stay at the periphery of the well, hence the 
Cell name Tissue Derivation Medium
Fold-
change
p-value 
(t-test)
T98G Brain Glioblastoma DMEM/Ham’s F-12 4.1 ± 1.8 <0.01
MNNG/HOS Bone Osteosarcoma EMEM 3.6 ± 1.0 <0.01
HepG2 Liver Carcinoma DMEM 3.3 ± 1.0 <0.01
A375 Skin Melanoma DMEM 2.5 ± 0.2 <0.01
HCT 116 Colon Carcinoma McCoy’s 5 A 2.5 ± 0.6 <0.01
MDA-MB-231 Breast Adenocarcinoma DMEM 2.3 ± 0.3 <0.01
A431* Skin Epidermoid carcinoma EMEM 2.4 ± 0.5 <0.01
MCF-7 Breast Adenocarcinoma EMEM 2.2 ± 0.3 <0.05
A549 Lung Carcinoma DMEM 2.1 ± 0.1 <0.01
SKOV3* Ovary Adenocarcinoma McCoy’s 5 A 2.1 ± 0.3 <0.01
MIA PaCa-2 Pancreas Carcinoma DMEM 1.3 ± 0.2 0.11
HeLa Cervix Adenocarcinoma DMEM 1.3 ± 0.1 0.07
AGS Stomach Adenocarcinoma Ham’s F-12 1.1 ± 0.0 0.26
LNCap Prostate Adenocarcinoma RPMI-1640 0.7 ± 0.2 0.51
Table 1. Growth of cancer cell lines cultured in the medium with LA717. The listed cell lines were cultured in 
3 wells of 96-well low-attachment plates in the indicated medium without (Blank) or with 0.030% (w/v) LA717 
for up to 7 days. The numbers of cultured cells were counted using an ATP assay method on day 7 and the fold-
change (Cell number in LA717-containing medium / Cell number in Blank) was calculated. Data represent 
means ± SD for 3 independent experiments. *100 ng/mL of HB-EGF (Heparin-binding EGF-like growth factor) 
was added for cell growth.
www.nature.com/scientificreports/
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automated imaging system often fails to capture such cell images. LA717-containing medium provided homo-
geneous dispersion of A549 cell spheroids (Fig. 5b; see also Fig. 1b,c). The growth inhibitory effect of anti-cancer 
drugs was reflected on the size and number of the spheroids as well as the cell number in each spheroid, that 
were all readily detectable by the imaging analyser thanks to the clear medium and the cells staying at the single 
focal plane (Fig. 5c–e). As shown in the quantitative analysis in Fig. 5f–h, Paclitaxel, Trametinib and MK-2206 
decreased all parameters; spheroid diameter, the cell number in individual spheroids and the number of sphe-
roids, in a concentration dependent manner. The IC50 values obtained by the imaging analyser were comparable 
to those obtained by the ATP assay (Supplementary Table S4). In addition, the automated image analyser was 
Figure 3. Microarray analyses on gene expression changes caused by 2D vs 3D and by LA717. (a-d) A549 cells 
were cultured with or without 0.030% (w/v) LA717 for 7 days under 2D or 3D conditions. Comparisons were 
made in indicated combinations. Scatter plots represent individual genes’ expression levels in each condition. 
Red, yellow and green lines indicate the range of ×2, ×3, ×5 differences. (e) The number of genes with greater 
than twofold changes in each comparison. (f–h) Real-time PCR analyses of CEACAM1 (f), 5 (g) and 6 (h) 
gene expression in 2D and 3D cultures. A549 cells were cultured on 96-well cell-attachable (2D, blue) or low-
attachment plates with 0.030% (w/v) LA717 (3D, red) for 4, 7 and 10 days. Data represent mean expression ± SD 
normalised by GAPDH gene for 3 independent experiments. Statistical significance was analysed with Tukey’s test.
www.nature.com/scientificreports/
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able to detect apoptosis inside the spheroid of Paclitaxel-treated A549 cells (Fig. 6a–d) by Paclitaxel, while no 
significant caspase activity was detected in cells treated with MK-2206 (Fig. 6e). This was in consistent with the 
observation shown in Fig. 4b. These data indicate that the 3D culture with LA717 is suitable for the HCA/HCS.
To further evaluate the use of LA717 in a large-scale screening, we performed a HTS/HCS using 384-well 
low-attachment plates and LA717-containing medium. The coefficient of variation (CV) and the Z’-factor for the 
plate, when counting A549 cell number using ATP assay after 5 days of culture, were 10.76 ± 1.94 and 0.67 ± 0.05, 
respectively. Given that the Z’-factor is above 0.5, the statistical dispersion of cell growth per well is in an accept-
able range. Supplementary Figures S4 and S5 show the growth-inhibitory effect of anti-cancer drugs, Paclitaxel, 
Trametinib and MK-2206, that were assessed using the 384-well low-attachment plates with LA717-containing 
medium with ATP assay (Supplementary Figure S4) and imaging analyser (Supplementary Figure S5). These 
results demonstrate that LA717-containing 3D culture is suitable for HTS/HCS with 384-well plates, which ena-
bles us to perform large-scale screening.
Discussion
We have demonstrated that the LA717 offers a new type of 3D culture method that has unique features and 
advantages. The main feature is that, when cells are seeded in the LA717-containing medium following dissocia-
tion, the cells uniformly disperse in the medium and does not gather to form clumps. This is due to the feature of 
LA717 that (1) it prevents new cell adhesion while allowing to maintain existing cell adhesion after cell division 
and (2) it keeps the movement of the liquid to a minimum by occupying the space, hence convection is kept min-
imum and the cells and spheroids stay at the same position. These features not only prevent cells from forming 
clumps and become necrotic, but also make the analyses effective, as the spheroids are relatively homogeneous 
in size over time and readily exposed to the medium. The system is especially useful for studying the effect of 
exogenous factors in the medium, as we have shown higher sensitivities to some of anti-cancer drugs compared 
to the conventional 2D system. The fact that the cells and spheroids tend to stay still in their position is advanta-
geous for capturing time-lapse movies. The high solubility of LA717 to the medium and its transparency are other 
advantages for the imaging analysis. In addition, the low viscosity of the medium enables practical handling of the 
medium. Thus, LA717 makes a virtual 3D culture possible in a liquid form.
Another unique feature is that LA717 does not serve as a scaffold. It is therefore more suitable for cancer cell 
studies such as drug screening and the evaluation, and not for non-cancerous cells such as epithelial cells and 
fibroblasts that require scaffolds. For these cell types, adding a certain amount of gel matrix together with LA717 
will allow formation of epithelial cysts and spindle shaped-morphology, respectively, keeping some space for 
Figure 4. Application of 3D culture with LA717 to anti-cancer drug evaluation. (a) A549 cells were grown 
at 1000 cells/well in 96-well cell-attachable plates in DMEM (2D) or in low-attachment plates with 0.030% 
(w/v) LA717 (3D). After 1 day of culture, anti-cancer drugs or DMSO (Control) were added. The cells were 
further cultured for 7 days and the cell number was counted using ATP assay. Data represent means ± SD of 3 
independent experiments. Statistical significance was analysed with Tukey’s test. (b) Anti-cancer drug-treated 
cells were prepared as in (a). The Y-axis indicates the Caspase 3/7-Glo value (apoptosis activity) normalised 
to the ATP value (cell number). Statistical significance was analysed with Dunnett’s test (vs. Control). Data 
represent means ± SD of 3 independent experiments.
www.nature.com/scientificreports/
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additional exogenous factors to test. Thus, LA717 has further potential applications yet to develop. At present, the 
feature of LA717 may be best presented in anti-cancer drug tests as shown in this study, where cells do not require 
scaffold and form homogeneous spheroids in the liquid medium, allowing the cells to be consistently exposed to 
dissolved drugs. Large-scale screening of anti-cancer drugs with HCA/HCS is also a well-suited application of 
Figure 5. The high content analysis of A549 cells treated with anti-cancer drugs. Anti-cancer drug-treated 
cells were prepared as in Fig. 3(a). (a–e) Fluorescent images of A549 spheroids stained with Hoechst 33342. 
A549 spheroids were cultured without (a) or with 0.030% (w/v) LA717 (b–d). They were treated with DMSO 
(a, b; control), 0.01 μM Paclitaxel (c), 0.03 μM Trametinib (d) or 1.0 μM MK-2206 (e) for 7 days. (f–h) Dose-
dependent effect of anti-cancer drugs on A549 cell growth. Graphs show the diameter of spheroids (f), the cell 
number in an A549 spheroid (g), and the total number of spheroids (diameter ≥50 μm) (h). Data represent 
means ± SD for 3 independent experiments.
www.nature.com/scientificreports/
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LA717, in which transparent and non-viscous medium makes auto-imaging and liquid-handling possible. It is 
anticipated that LA717 promotes applications of HCS to the increasingly demanding field such as personalised 
medicine using patients’ tumor cells. Cells’ sedimentation and even distribution on the plate is a definite advan-
tage not only for HCA/HCS but also for conventional time-lapse imaging.
One of the striking results in this study is that the cytotoxic effect of the AKT inhibitor MK-2206 is only 
evident in the 3D culture and not in 2D, whereas that of Paclitaxel, an anti-mitogenic drug, is similar in 2D and 
3D. Our result is consistent with the report by Riedl et al. that 3D-cultured spheroids show augmented response 
to AKT-mTOR or MEK inhibitors compared to 2D-cultured cells30. In addition, we found that elimination of 
serum from the medium weakens the growth-inhibitory effect of MK-2206 in the 3D condition while the effect 
of Paclitaxel was not affected. It would be interesting to know whether drugs working on signal transduction 
pathways tend to show more prominent effects in 3D cultured cells than in 2D, and whether the similar effects 
between 2D and 3D is a common feature for anti-mitogenic drugs. It is noteworthy that Trametinib and MK-2206 
have been reported to be of relatively low efficacy on cell growth inhibition compared to anti-mitogenic drugs 
Figure 6. Caspase-3/7 assay on anti-cancer drugs-treated A549 cells using HCA. (a–d) Fluorescent images of 
A549 spheroid stained with Hoechst 33342 and CellEventTM Caspase-3/7 Green Detection Reagent, taken using 
the Cellomics® ArrayScan® VTI. Images are the merged image (a), the outline of cells (b, Ch 1), nuclei (c, Ch2) 
and caspase-3/7 activity (d, Ch3). (e) Detection of activated Caspase-3/7 in A549 spheroids (diameter ≥50 μm). 
The intensity of CellEventTM staining was measured within the area outlined in (b) (blue line in (b) and red line 
in (d)). Y axis shows the intensity of CellEventTM Caspase 3/7 Green Detection Reagent compared to the control 
(DMSO-treated spheroids). Statistical significance was analysed by Dunnett’s test (vs. Control). Data represent 
means ± SD of 3 independent experiments.
www.nature.com/scientificreports/
1 0SCIeNTIFIC REPORts |  (2018) 8:3627  | DOI:10.1038/s41598-018-21950-5
when using 2D culture methods31–33. It is possible that the in vivo effect of drugs that target AKT or MEK is 
masked in conventional 2D cultures. In addition, it has been reported that 2D cell cultures induce phosphoryla-
tion of ERK1/2 and AKT in cancer cells compared to tumours xenografted in mice, thus resulting in high activity 
within the pathways and low sensitivity to the blockers30,34. In this respect, anti-cancer assay models employing 
3D cultures with LA717 are more relevant to in vivo conditions compared to those employing 2D cultures.
The analysis of the gene expression profile revealed that there was a relatively small difference between the presence 
and absence of LA717 in 3D, despite the apparent difference in the shape of the aggregate. This might be because the 
main difference caused by the presence or absence of LA717 is likely cell necrosis, which does not involve transcrip-
tional regulation, as is evident in apoptosis. In this regard, the fact that LA717 does not act as a microenvironmental 
factor is another benefit, allowing researchers to add exogenous factors of their choice for examination.
Agar has conventionally been used for soft agar colony formation assays which evaluate the ability of cells 
to grow in anchorage-independent conditions35. The principle of LA717 is similar to this, utilising the nature of 
agar not serving as a scaffold. Indeed, there was little difference in the efficacy of MK2206 on cancer cell growth 
between 3D cultures with LA717 and in soft-agar. The major difference is that LA717 is highly soluble, achieved 
by the low molecular weight and optimal concentration of it. Therefore, LA717 can be used similarly to normal 
agar for cell culture with the advantage of being able to handle it as a liquid. In this study, application of 3D 
cultures with LA717 was limited to transformed cells that have the capacity to perform anchorage-independent 
growth as one of the hallmarks of cancer cells. However, using 3D culture with LA717 may also be useful to exam-
ination of non-transformed cells, such as ES/iPS cells, that grow anchorage-independently36.
In conclusion, a novel 3D culture method using LA717 improves the growth of spheroid-forming cells, prom-
ising it as an effective and sensitive assay approach for detecting changes in cell proliferation, function and drug 
sensitivity. LA717 enables 3D culture to be a practical, robust and reproducible method, which promotes the 
effective performance of large-scale assays as well as cell biological studies.
Materials and Methods
Compounds and reagents. Low molecular weight (Ultra-agar Ina, average MW 43,000) and standard (S-6, 
average MW 290,000) agar was purchased from Ina Food Industry Co., Ltd. (Nagano, Japan). To prepare agar 
stock solution for cell cultures, agar was suspended in pure water to 1.0% (w/v) and dissolved by stirring at 90 °C. 
The aqueous solution was sterilized at 121 °C for 20 minutes by autoclave. The solution was then added to cell 
culture media at given concentrations with stirring at room temperature.
Trametinib and MK-2206 were obtained from Santa Cruz (Texas, USA). Paclitaxel was purchased from Wako 
Pure Chemical Industries (Osaka, Japan).
Cancer cell lines. All human cancer cell lines used in this study were commercially available. The human 
cancer cell lines A549, MDA-MB-231, SKOV3, HCT116, MCF-7, A431, T98G, AGS, HeLa and HepG2 were 
obtained from DS Pharma Biomedical (Osaka, Japan). Other cell lines A375, MNNG/HOS, MIAPaCa-2 and 
LNCap cells were obtained from American Type Culture Collection (Virginia, USA). A549, A375, HeLa, HepG2, 
MDA-MB-231 and MIA PaCa-2 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% 
fetal bovine serum (FBS). HCT116 and SKOV3 cells were cultured in McCoy’s 5 A medium with 10% FBS. MCF-
7, MNNG/HOS and A431 cells were cultured in Eagle’s Minimum Essential Medium (EMEM) with 10% FBS. 
LNCap cells were cultured in Roswell Park Memorial Institute Medium 1640 (RPMI1640) with 10% FBS. These 
media were supplemented with a 1% penicillin-streptomycin mix (Sigma-Aldrich, Missouri, USA). Cells were all 
cultured at 37 °C in a humidified atmosphere with 5% CO2.
Cell culture using medium with LA717. Each human cancer cell line was seeded at a density of 5,000-
20,000 cells/mL into the appropriate medium containing 0.03% (w/v) of LA717, and was dispensed into 96-well 
flat-bottom low-attachment plates using 100–200 μL/well. For the monolayer culture method (2D), each cancer 
cell line was inoculated at a density of 2,000–15,000 cells/mL in the medium without LA717, and dispensed into 
96-well flat-bottom cell-attachable plates (Corning Incorporated) using 100–200 μL/well. These plates were cul-
tured unstirred for 2–10 days.
For the anti-cancer drug test, medium containing a 10-fold concentration of various anti-cancer drugs and 
0.03% (w/v) LA717-containing cell culture media were combined at the ratio of 1:9.
Cell proliferation assay. For the cell proliferation assay, cells were counted as follows: for the WST-8 assay, 
WST-8 solution (Dojindo Laboratories, Kumamoto, Japan) was added to the cell culture at the 1/10 of the volume 
and incubated at 37 °C for 100 minutes. Viable cells were counted by measurement of the absorbance at 450 nm 
using the absorbance spectrometer SpectraMax® 190 (Molecular Devices, California, USA). For the ATP assay, 
an equal volume of ATP reagent (CellTiter-Glo® Luminescent Cell Viability Assay; Promega, Wisconsin, USA) 
was added to the culture medium and the luminescence intensity (Relative Light Unit (RLU) value) was meas-
ured using FlexStation3 (Molecular Devices, California, USA). For the trypan blue exclusion assay, spheroids 
were dissociated to single cells by trypsin-EDTA treatment for 10 min and then cells were stained with an equal 
volume of 0.4% (w/v) trypan blue solution (Life Technologies, California, USA). Viable cells were counted using 
an automated cell counter (Bio-Rad, California, USA, TC20).
Cell culture on LA717-coated plates. LA717 aqueous solution (1.0% (w/v), 500 μL/well) was added to 12-well 
flat bottom plates (Corning Incorporated, #3513). After incubation for 60 minutes at room temperature, A549 cells were 
plated on the LA717-coated plates at a density of 100,000 cells/2 mL/well and were cultured for 5 days. The cultured cells 
were observed under the light microscope at 100-fold magnification (Olympus, Tokyo, Japan).
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Microarray analysis. Total RNA was isolated from 7-day cultured A549 cells using RNeasy Kit (Qiagen, 
California, USA) according to manufacturer’s protocol. Each RNA sample was analysed using a GeneChip® 
Human Gene 2.0 ST Array (Affimetrix, California, USA and Kurabo, Osaka, Japan). Up- and down-regulated 
genes with at least two fold changes were selected using DNA MicroArray Viewer Software (Kurabo). All data 
are MIAME compliant and the raw data were deposited in the Gene Expression Omnibus (accession number; 
GSE103702, GSE103845).
Real-time PCR. Real-time PCR was carried out for 40 to 45 cycles of 15 seconds at 95 °C and 1 minutes at 
60 °C using ABI PRISM® 7700 Sequence Detector (Applied Biosystems, California, USA). All Taqman primers 
and probes were obtained from Applied Biosystems; GAPDH (Hs02758991_g1), CEACAM1 (Hs00989786_m1), 
CEACAM5 (Hs00944025_m1) and CEACAM6 (Hs03645554_m1).
Apoptosis assay. Caspase 3/7 reagent (Caspase-Glo® 3/7, Promega) was added to the culture medium after 
4 days of cell culture as appropriate. Following incubation for 1 hour at room temperature, luminescence intensity 
(RLU value) was measured using FlexStation3®. The values were normalised to the ATP value.
High content analysis. For quantitative analyses for the size and distribution of spheroids and anti-cancer 
drug evaluation, spheroids were stained with 10 μg/mL Hoechst 33342 in phenol red-free DMEM. For caspase-3/7 
assay, the staining solution which consisted of DMEM without phenol red, 2 μM CellEvent™ Caspase-3/7 
(ThermoFisherScientific, Massachusetts, USA) and 10 μg/mL Hoechst 33342 was added to the culture medium.
After incubation for 45–60 min at 37 °C, fluorescent images were automatically taken, stored, and analysed 
by Cellomics®ArrayScan® VTI. Ten fields were analysed in each well with a × 10 objective. The morphology 
algorithm in ArrayScan® VTI was used to detect the saturated fluorescence of Hoechst 33342 that allowed us 
to identify the outline of spheroids at channel 1, whilst the fluorescence of Hoechst 33342 identifying cell nuclei 
was detected at channel 2. The fluorescence of CellEvent™ Caspase-3/7 as activated caspase-3/7 was detected at 
channel 3 within the area gated by the outline of spheroids.
Statistical analysis. All results are presented as the mean ± standard deviation (SD). Statistical significance 
was analysed with Student’s t-test, Dunnett’s test, or Tukey’s test as indicated in each legend, using EXSAS ver. 
7.1.6.1 (Arm Systex, Osaka, Japan). The level of significance was set at 0.05 unless stated otherwise.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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